M&A Deal Summary |
|
|---|---|
| Date | 2025-11-14 |
| Target | Cidara Therapeutics |
| Sector | Life Science |
| Buyer(s) | Merck |
| Deal Type | Add-on Acquisition |
| Deal Value | 9.2B USD |
| Advisor(s) | Evercore Group Goldman Sachs (Financial) Cooley (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1891 |
| Sector | Life Science |
| Employees | 70,000 |
| Revenue | 64.2B USD (2024) |
Merck is a global healthcare company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The Company’s operations are comprised of four operating segments: Pharmaceutical, Animal Health, Consumer Care and Alliances. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products. Merck was established in 1891 and is based in Rahway, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 37 of 37 |
| Sector: Life Science M&A | 34 of 34 |
| Type: Add-on Acquisition M&A Deals | 35 of 35 |
| State: California M&A | 8 of 8 |
| Country: United States M&A | 28 of 28 |
| Year: 2025 M&A | 2 of 2 |
| Size (of disclosed) | 6 of 29 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-07-09 |
Verona Pharma
London, United Kingdom Verona Pharma is a biopharmaceutical company focused on the development of innovative prescription medicines to treat respiratory diseases with significant medical unmet needs. Verona Pharma was founded in 2005 and is based in London, England. |
Buy | $10.0B |
